SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3oaj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GMK_B_DVAB6_0 (GRAMICIDIN A)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 4	VAL A 86 TRP A 95 ALA A 150 VAL A 87	None	1.41A	1gmkA-3oajA: undetectable 1gmkB-3oajA: undetectable	1gmkA-3oajA: 4.72 1gmkB-3oajA: 4.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IEP_B_STIB202_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 7	VAL A 130 VAL A 82 ILE A 109 LEU A 160	None	1.02A	1iepB-3oajA: undetectable	1iepB-3oajA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQP_A_FCNA4002_1 (PROBABLE FOSFOMYCIN RESISTANCE PROTEIN)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 218 TYR A 256 GLU A 266 HIS A 11 THR A 13	ZN A 500 ( 3.4A) SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A) SO4 A 501 (-3.1A)	0.31A	1lqpA-3oajA: 10.1 1lqpB-3oajA: 10.1	1lqpA-3oajA: 15.77 1lqpB-3oajA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQP_B_FCNB4001_1 (PROBABLE FOSFOMYCIN RESISTANCE PROTEIN)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 11 THR A 13 HIS A 218 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) SO4 A 501 (-3.1A) ZN A 500 ( 3.4A) SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	0.32A	1lqpA-3oajA: 10.1 1lqpB-3oajA: 10.1	1lqpA-3oajA: 15.77 1lqpB-3oajA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NKI_A_PPFA5001_1 (PROBABLE FOSFOMYCIN RESISTANCE PROTEIN)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 9	HIS A 218 TYR A 256 GLU A 266 HIS A 11 THR A 13	ZN A 500 ( 3.4A) SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A) SO4 A 501 (-3.1A)	0.30A	1nkiA-3oajA: 10.2 1nkiB-3oajA: 10.0	1nkiA-3oajA: 15.77 1nkiB-3oajA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NKI_B_PPFB5002_1 (PROBABLE FOSFOMYCIN RESISTANCE PROTEIN)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 9	HIS A 11 THR A 13 HIS A 218 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) SO4 A 501 (-3.1A) ZN A 500 ( 3.4A) SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	0.30A	1nkiA-3oajA: 10.2 1nkiB-3oajA: 10.0	1nkiA-3oajA: 15.77 1nkiB-3oajA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_B_SAMB500_1 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 8	ASP A 42 ASN A 40 PHE A 65 ARG A 247	None	1.08A	1rqpC-3oajA: undetectable	1rqpC-3oajA: 24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S1X_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 8	LEU A 30 GLY A 153 LEU A 127 TYR A 26	None	0.98A	1s1xA-3oajA: undetectable	1s1xA-3oajA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WG8_A_SAMA3142_0 (PREDICTED S-ADENOSYLMETHIONINE -DEPENDENT METHYLTRANSFERASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 12	THR A 83 GLY A 156 GLY A 155 GLY A 153 ASP A 200	None	1.23A	1wg8A-3oajA: undetectable	1wg8A-3oajA: 23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_A_PNXA1435_1 (CHITINASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 6	TRP A 221 GLY A 155 PHE A 154 SER A 84	None	1.31A	2a3cA-3oajA: undetectable	2a3cA-3oajA: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_B_PNXB2434_1 (CHITINASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 6	TRP A 221 GLY A 155 PHE A 154 SER A 84	None	1.27A	2a3cB-3oajA: undetectable	2a3cB-3oajA: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C6N_A_LPRA705_1 (ANGIOTENSIN-CONVERTI NG ENZYME, SOMATIC ISOFORM)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 12	ALA A 254 HIS A 11 GLU A 266 HIS A 218 TYR A 50	SO4 A 501 ( 4.6A) ZN A 500 ( 3.3A) ZN A 500 ( 2.1A) ZN A 500 ( 3.4A) None	1.21A	2c6nA-3oajA: undetectable	2c6nA-3oajA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V7U_A_SAMA1299_0 (5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 8	ASP A 42 ASN A 40 PHE A 65 ARG A 247	None	1.09A	2v7uA-3oajA: undetectable	2v7uA-3oajA: 24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_J_TFPJ201_1 (PROTEIN S100-A4)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 8	PHE A 51 PHE A 64 GLY A 284 PHE A 25	None	1.09A	3ko0B-3oajA: undetectable 3ko0J-3oajA: undetectable	3ko0B-3oajA: 15.87 3ko0J-3oajA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_L_TFPL201_1 (PROTEIN S100-A4)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 7	GLY A 284 PHE A 25 PHE A 51 PHE A 64	None	1.16A	3ko0L-3oajA: undetectable 3ko0N-3oajA: undetectable	3ko0L-3oajA: 15.87 3ko0N-3oajA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_S_TFPS201_1 (PROTEIN S100-A4)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 7	PHE A 51 PHE A 64 GLY A 284 PHE A 25	None	1.06A	3ko0K-3oajA: undetectable 3ko0S-3oajA: undetectable	3ko0K-3oajA: 15.87 3ko0S-3oajA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_T_TFPT201_1 (PROTEIN S100-A4)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 7	PHE A 51 PHE A 64 GLY A 284 PHE A 25	None	1.12A	3ko0R-3oajA: undetectable 3ko0T-3oajA: undetectable	3ko0R-3oajA: 15.87 3ko0T-3oajA: 15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUG_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 12	GLY A 76 ARG A 188 THR A 158 ALA A 157 ASP A 200	None	0.66A	3sugA-3oajA: undetectable	3sugA-3oajA: 19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WQW_A_GCSA502_1 (CHITINASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 5	TRP A 232 GLY A 176 ALA A 3 PHE A 257	None	1.32A	3wqwA-3oajA: undetectable	3wqwA-3oajA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WXO_A_NIZA802_1 (CATALASE-PEROXIDASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 8	LEU A 171 ASN A 197 GLY A 196 ILE A 9	None	0.88A	3wxoA-3oajA: undetectable	3wxoA-3oajA: 20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IR0_A_FCNA202_1 (METALLOTHIOL TRANSFERASE FOSB 2)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A)	1.50A	4ir0A-3oajA: 7.4 4ir0B-3oajA: 9.2	4ir0A-3oajA: 21.18 4ir0B-3oajA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IR0_B_FCNB202_1 (METALLOTHIOL TRANSFERASE FOSB 2)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 11 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.44A	4ir0A-3oajA: 7.4 4ir0B-3oajA: 9.2	4ir0A-3oajA: 21.18 4ir0B-3oajA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J7X_B_SASB804_1 (SEPIAPTERIN REDUCTASE)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 12	SER A 161 LEU A 159 PHE A 265 MET A 175 GLY A 176	None	1.25A	4j7xB-3oajA: undetectable	4j7xB-3oajA: 24.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JD1_A_FCNA202_1 (METALLOTHIOL TRANSFERASE FOSB 2)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	6 / 12	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11 TYR A 50	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A) None	1.43A	4jd1A-3oajA: 7.4 4jd1B-3oajA: 7.5	4jd1A-3oajA: 21.18 4jd1B-3oajA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JD1_B_FCNB203_1 (METALLOTHIOL TRANSFERASE FOSB 2)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	6 / 12	HIS A 11 TYR A 50 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) None ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.39A	4jd1A-3oajA: 7.4 4jd1B-3oajA: 7.5	4jd1A-3oajA: 21.18 4jd1B-3oajA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH3_A_FCNA204_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	6 / 12	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11 TYR A 50	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A) None	1.40A	4jh3A-3oajA: 8.7 4jh3B-3oajA: 8.8	4jh3A-3oajA: 18.69 4jh3B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH3_B_FCNB203_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 11 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.44A	4jh3A-3oajA: 8.7 4jh3B-3oajA: 8.8	4jh3A-3oajA: 18.69 4jh3B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH4_A_FCNA202_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A)	1.48A	4jh4A-3oajA: 8.4 4jh4B-3oajA: 8.7	4jh4A-3oajA: 18.69 4jh4B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH4_B_FCNB202_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 11 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.47A	4jh4A-3oajA: 8.4 4jh4B-3oajA: 8.7	4jh4A-3oajA: 18.69 4jh4B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH5_A_FCNA202_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A)	1.45A	4jh5A-3oajA: 8.8 4jh5B-3oajA: 8.7	4jh5A-3oajA: 18.69 4jh5B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH5_B_FCNB203_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 11	HIS A 11 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.46A	4jh5A-3oajA: 8.8 4jh5B-3oajA: 8.7	4jh5A-3oajA: 18.69 4jh5B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH6_A_FCNA202_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A)	1.45A	4jh6A-3oajA: 8.8 4jh6B-3oajA: 8.8	4jh6A-3oajA: 18.69 4jh6B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH6_B_FCNB202_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 11 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.46A	4jh6A-3oajA: 8.8 4jh6B-3oajA: 8.8	4jh6A-3oajA: 18.69 4jh6B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH8_A_FCNA204_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 218 ARG A 249 TYR A 256 GLU A 266 HIS A 11	ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A) ZN A 500 ( 3.3A)	1.45A	4jh8A-3oajA: 8.7 4jh8B-3oajA: 8.5	4jh8A-3oajA: 18.69 4jh8B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JH8_B_FCNB203_1 (METALLOTHIOL TRANSFERASE FOSB)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 11 HIS A 218 ARG A 249 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) ZN A 500 ( 3.4A) None SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	1.45A	4jh8A-3oajA: 8.7 4jh8B-3oajA: 8.5	4jh8A-3oajA: 18.69 4jh8B-3oajA: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L39_A_SALA602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 6	LEU A 127 TYR A 85 ILE A 12 GLY A 81	None	1.00A	4l39A-3oajA: undetectable	4l39A-3oajA: 18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 8	THR A 23 GLY A 17 VAL A 16 ASP A 121	None	0.84A	4qvvK-3oajA: undetectable 4qvvL-3oajA: undetectable	4qvvK-3oajA: 21.84 4qvvL-3oajA: 19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 4	GLY A 196 LEU A 32 PHE A 51 ILE A 62	None	0.92A	4xv2A-3oajA: undetectable	4xv2A-3oajA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V3D_A_FCNA205_1 (FOSFOMYCIN RESISTANCE PROTEIN)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	5 / 10	HIS A 11 THR A 13 HIS A 218 TYR A 256 GLU A 266	ZN A 500 ( 3.3A) SO4 A 501 (-3.1A) ZN A 500 ( 3.4A) SO4 A 501 (-4.7A) ZN A 500 ( 2.1A)	0.33A	5v3dA-3oajA: 9.6 5v3dB-3oajA: 9.5	5v3dA-3oajA: 19.03 5v3dB-3oajA: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN5_A_LLLA301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 6	ASP A 200 TYR A 116 GLU A 114 GLU A 134	None	1.21A	6mn5A-3oajA: undetectable	6mn5A-3oajA: 15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN5_B_LLLB301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 7	ASP A 200 TYR A 116 GLU A 114 GLU A 134	None	1.11A	6mn5B-3oajA: undetectable	6mn5B-3oajA: 15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN5_C_LLLC301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3oaj	PUTATIVE RING-CLEAVING DIOXYGENASE MHQO (Bacillus subtilis)	4 / 6	ASP A 200 TYR A 116 GLU A 114 GLU A 134	None	1.25A	6mn5C-3oajA: undetectable	6mn5C-3oajA: 15.98

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GMK_B_DVAB6_0","GRAMICIDIN A","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"VAL A  86;TRP A  95;ALA A 150;VAL A  87","None","1.41A","1gmkA-3oajA:undetectable;1gmkB-3oajA:undetectable","1gmkA-3oajA:4.72;1gmkB-3oajA:4.72"],["1IEP_B_STIB202_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"VAL A 130;VAL A  82;ILE A 109;LEU A 160","None","1.02A","1iepB-3oajA:undetectable","1iepB-3oajA:21.10"],["1LQP_A_FCNA4002_1","PROBABLE FOSFOMYCIN RESISTANCE PROTEIN;PROBABLE FOSFOMYCIN RESISTANCE PROTEIN","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;TYR A 256;GLU A 266;HIS A  11;THR A  13"," ZN A 500 ( 3.4A);SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A);SO4 A 501 (-3.1A)","0.31A","1lqpA-3oajA:10.1;1lqpB-3oajA:10.1","1lqpA-3oajA:15.77;1lqpB-3oajA:15.77"],["1LQP_B_FCNB4001_1","PROBABLE FOSFOMYCIN RESISTANCE PROTEIN;PROBABLE FOSFOMYCIN RESISTANCE PROTEIN","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;THR A  13;HIS A 218;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A);SO4 A 501 (-3.1A); ZN A 500 ( 3.4A);SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","0.32A","1lqpA-3oajA:10.1;1lqpB-3oajA:10.1","1lqpA-3oajA:15.77;1lqpB-3oajA:15.77"],["1NKI_A_PPFA5001_1","PROBABLE FOSFOMYCIN RESISTANCE PROTEIN;PROBABLE FOSFOMYCIN RESISTANCE PROTEIN","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;TYR A 256;GLU A 266;HIS A  11;THR A  13"," ZN A 500 ( 3.4A);SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A);SO4 A 501 (-3.1A)","0.30A","1nkiA-3oajA:10.2;1nkiB-3oajA:10.0","1nkiA-3oajA:15.77;1nkiB-3oajA:15.77"],["1NKI_B_PPFB5002_1","PROBABLE FOSFOMYCIN RESISTANCE PROTEIN;PROBABLE FOSFOMYCIN RESISTANCE PROTEIN","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;THR A  13;HIS A 218;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A);SO4 A 501 (-3.1A); ZN A 500 ( 3.4A);SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","0.30A","1nkiA-3oajA:10.2;1nkiB-3oajA:10.0","1nkiA-3oajA:15.77;1nkiB-3oajA:15.77"],["1RQP_B_SAMB500_1","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"ASP A  42;ASN A  40;PHE A  65;ARG A 247","None","1.08A","1rqpC-3oajA:undetectable","1rqpC-3oajA:24.38"],["1S1X_A_NVPA999_1","REVERSE TRANSCRIPTASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"LEU A  30;GLY A 153;LEU A 127;TYR A  26","None","0.98A","1s1xA-3oajA:undetectable","1s1xA-3oajA:21.23"],["1WG8_A_SAMA3142_0","PREDICTED S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"THR A  83;GLY A 156;GLY A 155;GLY A 153;ASP A 200","None","1.23A","1wg8A-3oajA:undetectable","1wg8A-3oajA:23.41"],["2A3C_A_PNXA1435_1","CHITINASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"TRP A 221;GLY A 155;PHE A 154;SER A  84","None","1.31A","2a3cA-3oajA:undetectable","2a3cA-3oajA:22.03"],["2A3C_B_PNXB2434_1","CHITINASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"TRP A 221;GLY A 155;PHE A 154;SER A  84","None","1.27A","2a3cB-3oajA:undetectable","2a3cB-3oajA:22.03"],["2C6N_A_LPRA705_1","ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"ALA A 254;HIS A  11;GLU A 266;HIS A 218;TYR A  50","SO4 A 501 ( 4.6A); ZN A 500 ( 3.3A); ZN A 500 ( 2.1A); ZN A 500 ( 3.4A);None","1.21A","2c6nA-3oajA:undetectable","2c6nA-3oajA:18.24"],["2V7U_A_SAMA1299_0","5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"ASP A  42;ASN A  40;PHE A  65;ARG A 247","None","1.09A","2v7uA-3oajA:undetectable","2v7uA-3oajA:24.38"],["3KO0_J_TFPJ201_1","PROTEIN S100-A4;PROTEIN S100-A4","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"PHE A  51;PHE A  64;GLY A 284;PHE A  25","None","1.09A","3ko0B-3oajA:undetectable;3ko0J-3oajA:undetectable","3ko0B-3oajA:15.87;3ko0J-3oajA:15.87"],["3KO0_L_TFPL201_1","PROTEIN S100-A4;PROTEIN S100-A4","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"GLY A 284;PHE A  25;PHE A  51;PHE A  64","None","1.16A","3ko0L-3oajA:undetectable;3ko0N-3oajA:undetectable","3ko0L-3oajA:15.87;3ko0N-3oajA:15.87"],["3KO0_S_TFPS201_1","PROTEIN S100-A4;PROTEIN S100-A4","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"PHE A  51;PHE A  64;GLY A 284;PHE A  25","None","1.06A","3ko0K-3oajA:undetectable;3ko0S-3oajA:undetectable","3ko0K-3oajA:15.87;3ko0S-3oajA:15.87"],["3KO0_T_TFPT201_1","PROTEIN S100-A4;PROTEIN S100-A4","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"PHE A  51;PHE A  64;GLY A 284;PHE A  25","None","1.12A","3ko0R-3oajA:undetectable;3ko0T-3oajA:undetectable","3ko0R-3oajA:15.87;3ko0T-3oajA:15.87"],["3SUG_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"GLY A  76;ARG A 188;THR A 158;ALA A 157;ASP A 200","None","0.66A","3sugA-3oajA:undetectable","3sugA-3oajA:19.28"],["3WQW_A_GCSA502_1","CHITINASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"TRP A 232;GLY A 176;ALA A   3;PHE A 257","None","1.32A","3wqwA-3oajA:undetectable","3wqwA-3oajA:21.18"],["3WXO_A_NIZA802_1","CATALASE-PEROXIDASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"LEU A 171;ASN A 197;GLY A 196;ILE A   9","None","0.88A","3wxoA-3oajA:undetectable","3wxoA-3oajA:20.78"],["4IR0_A_FCNA202_1","METALLOTHIOL TRANSFERASE FOSB 2;METALLOTHIOL TRANSFERASE FOSB 2","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A)","1.50A","4ir0A-3oajA:7.4;4ir0B-3oajA:9.2","4ir0A-3oajA:21.18;4ir0B-3oajA:21.18"],["4IR0_B_FCNB202_1","METALLOTHIOL TRANSFERASE FOSB 2;METALLOTHIOL TRANSFERASE FOSB 2","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A); ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.44A","4ir0A-3oajA:7.4;4ir0B-3oajA:9.2","4ir0A-3oajA:21.18;4ir0B-3oajA:21.18"],["4J7X_B_SASB804_1","SEPIAPTERIN REDUCTASE","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"SER A 161;LEU A 159;PHE A 265;MET A 175;GLY A 176","None","1.25A","4j7xB-3oajA:undetectable","4j7xB-3oajA:24.51"],["4JD1_A_FCNA202_1","METALLOTHIOL TRANSFERASE FOSB 2;METALLOTHIOL TRANSFERASE FOSB 2","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",6,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11;TYR A  50"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A);None","1.43A","4jd1A-3oajA:7.4;4jd1B-3oajA:7.5","4jd1A-3oajA:21.18;4jd1B-3oajA:21.18"],["4JD1_B_FCNB203_1","METALLOTHIOL TRANSFERASE FOSB 2;METALLOTHIOL TRANSFERASE FOSB 2","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",6,"HIS A  11;TYR A  50;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A);None; ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.39A","4jd1A-3oajA:7.4;4jd1B-3oajA:7.5","4jd1A-3oajA:21.18;4jd1B-3oajA:21.18"],["4JH3_A_FCNA204_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",6,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11;TYR A  50"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A);None","1.40A","4jh3A-3oajA:8.7;4jh3B-3oajA:8.8","4jh3A-3oajA:18.69;4jh3B-3oajA:18.69"],["4JH3_B_FCNB203_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A); ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.44A","4jh3A-3oajA:8.7;4jh3B-3oajA:8.8","4jh3A-3oajA:18.69;4jh3B-3oajA:18.69"],["4JH4_A_FCNA202_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A)","1.48A","4jh4A-3oajA:8.4;4jh4B-3oajA:8.7","4jh4A-3oajA:18.69;4jh4B-3oajA:18.69"],["4JH4_B_FCNB202_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A); ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.47A","4jh4A-3oajA:8.4;4jh4B-3oajA:8.7","4jh4A-3oajA:18.69;4jh4B-3oajA:18.69"],["4JH5_A_FCNA202_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A)","1.45A","4jh5A-3oajA:8.8;4jh5B-3oajA:8.7","4jh5A-3oajA:18.69;4jh5B-3oajA:18.69"],["4JH5_B_FCNB203_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A); ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.46A","4jh5A-3oajA:8.8;4jh5B-3oajA:8.7","4jh5A-3oajA:18.69;4jh5B-3oajA:18.69"],["4JH6_A_FCNA202_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A)","1.45A","4jh6A-3oajA:8.8;4jh6B-3oajA:8.8","4jh6A-3oajA:18.69;4jh6B-3oajA:18.69"],["4JH6_B_FCNB202_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A); ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.46A","4jh6A-3oajA:8.8;4jh6B-3oajA:8.8","4jh6A-3oajA:18.69;4jh6B-3oajA:18.69"],["4JH8_A_FCNA204_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A 218;ARG A 249;TYR A 256;GLU A 266;HIS A  11"," ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A); ZN A 500 ( 3.3A)","1.45A","4jh8A-3oajA:8.7;4jh8B-3oajA:8.5","4jh8A-3oajA:18.69;4jh8B-3oajA:18.69"],["4JH8_B_FCNB203_1","METALLOTHIOL TRANSFERASE FOSB;METALLOTHIOL TRANSFERASE FOSB","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;HIS A 218;ARG A 249;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A); ZN A 500 ( 3.4A);None;SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","1.45A","4jh8A-3oajA:8.7;4jh8B-3oajA:8.5","4jh8A-3oajA:18.69;4jh8B-3oajA:18.69"],["4L39_A_SALA602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"LEU A 127;TYR A  85;ILE A  12;GLY A  81","None","1.00A","4l39A-3oajA:undetectable","4l39A-3oajA:18.78"],["4QVV_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"THR A  23;GLY A  17;VAL A  16;ASP A 121","None","0.84A","4qvvK-3oajA:undetectable;4qvvL-3oajA:undetectable","4qvvK-3oajA:21.84;4qvvL-3oajA:19.30"],["4XV2_A_P06A801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"GLY A 196;LEU A  32;PHE A  51;ILE A  62","None","0.92A","4xv2A-3oajA:undetectable","4xv2A-3oajA:20.35"],["5V3D_A_FCNA205_1","FOSFOMYCIN RESISTANCE PROTEIN;FOSFOMYCIN RESISTANCE PROTEIN","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",5,"HIS A  11;THR A  13;HIS A 218;TYR A 256;GLU A 266"," ZN A 500 ( 3.3A);SO4 A 501 (-3.1A); ZN A 500 ( 3.4A);SO4 A 501 (-4.7A); ZN A 500 ( 2.1A)","0.33A","5v3dA-3oajA:9.6;5v3dB-3oajA:9.5","5v3dA-3oajA:19.03;5v3dB-3oajA:19.03"],["6MN5_A_LLLA301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"ASP A 200;TYR A 116;GLU A 114;GLU A 134","None","1.21A","6mn5A-3oajA:undetectable","6mn5A-3oajA:15.98"],["6MN5_B_LLLB301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"ASP A 200;TYR A 116;GLU A 114;GLU A 134","None","1.11A","6mn5B-3oajA:undetectable","6mn5B-3oajA:15.98"],["6MN5_C_LLLC301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3oaj","PUTATIVE RING-CLEAVING DIOXYGENASE MHQO","Bacillus subtilis",4,"ASP A 200;TYR A 116;GLU A 114;GLU A 134","None","1.25A","6mn5C-3oajA:undetectable","6mn5C-3oajA:15.98"]]